ANIP ANI Pharmaceuticals Corp: Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan
Risks of stagnation in niche generics are mitigated by stable demand for chronic medications for ANI Pharmaceuticals (ANIP). The company's EV/EBITDA metric visualizes these fluctuations, where the 7.38 level captures this indicator. Growth is driven by licensing partnerships and contract manufacturing. Logistics optimization and the diversification of raw material streams provide additional resilience, eliminating disruptions in the supply of finished medicines.
Rincian metrik komprehensif lan analitis anipharmaceuticals.com (ANIP)
- rega pasar lan target rega analis:
- data kapitalisasi saham perusahaan:
- rincian valuasi buku bisnis:
- statistik kawajiban utang lan likuiditas:
Utang marang Ekuitas ANI Pharmaceuticals|ANIP - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal ANI Pharmaceuticals, Inc.|ANIP - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku ANI Pharmaceuticals Corp|ANIP - Tanggungan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan ANI Pharmaceuticals|Indikator likuiditas cepet anipharmaceuticals.com
- rincian asil keuangan lan kelipatan valuasi:
ANIP - Bathi pungkasan|Bathi sing dikarepake ANI Pharmaceuticals|ANIP - Kapitalisasi marang bathi resik|Pangali Forward P/E ANI Pharmaceuticals|ANIP - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA ANI Pharmaceuticals Corp|ANIP - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan ANI Pharmaceuticals|ANIP - Bathi saben saham sajroning taun lumaku|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan anipharmaceuticals.com|ANIP - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep ANI Pharmaceuticals
Analisis fundamental perusahaan:ANIP (ANI Pharma)
Investors are assessing the potential of ANI Pharmaceuticals (ANIP) through the enterprise value to EBITDA ratio, which allows them to neutralize the impact of debt loads and tax regimes. The current EV/EBITDA multiple for ANI Pharmaceuticals (ANIP) reflects the efficiency of the Alimera Sciences integration and the growth in Cortrophin sales, helping to determine if the asset is undervalued against a backdrop of strong cash flow.
Analisis pesaing ANI Pharmaceuticals
Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Haleon Group HLN|Kenvue Health (KVUE) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|VRNA: Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|jyongbio.com - Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan|LGND: Pangali EV/EBITDA|Amneal Pharmaceuticals, Inc. - Nilai bisnis marang bathi operasional sadurunge panyusutan|PRGO (Perrigo Company) - Pangali EV/EBITDA|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Alvotech Biopharmaceuticals ALVO|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Liquidia Corporation (LQDA)|GLPG (glpg.com) - Nilai bisnis marang bathi operasional sadurunge panyusutan|Pangali EV/EBITDA MNKD (MannKind)|Pangali EV/EBITDA Amphastar Pharmaceuticals Inc AMPH|PCRX - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|SPRY (ARS Corp) - Nilai perusahaan marang bathi operasional sadurunge panyusutan|TBPH: Pangali EV/EBITDA|AQST - Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan SCPH|TECX: Nilai bisnis marang bathi operasional sadurunge panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Tonix Pharmaceuticals Inc. (TNXP)|SXTC: Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan|Pangali EV/EBITDA EPRX (Eupraxia Pharmaceuticals Inc.)|Nilai bisnis marang bathi operasional sadurunge panyusutan BHST|eXoZymes - Pangali EV/EBITDA|ORMP - Pangali EV/EBITDA|enterabio.com (ENTX) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|MindWalk Therapeutics - Nilai bisnis marang bathi operasional sadurunge panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan ABVC BioPharma|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan cumberlandpharma.com (CPIX)|Pangali EV/EBITDA QNTM|Pangali EV/EBITDA FibroGen Inc (FGEN)|Pangali EV/EBITDA TELO (Telomir Pharma)|RANI - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Synergy CHC Corporation - Pangali EV/EBITDA|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Rallybio Corporation|LEXX (lexariabioscience.com) - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Pulmatrix Inc (PULM) - Pangali EV/EBITDA|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan PTHL|APM (Aptorum) - Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan|Pangali EV/EBITDA LYRA|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan impactbiomedinc.com|Pangali EV/EBITDA TNFA (TNF Pharmaceuticals, Inc.)|YCBD - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|PainReform Limited - Pangali EV/EBITDA|CYTO - Pangali EV/EBITDA|Lipella Pharmaceuticals (LIPO) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|OPTN (optinose.com) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Pieris Pharmaceuticals, Inc.|Procaps Group (PROC) - Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan|Pangali EV/EBITDA PTPI|Pangali EV/EBITDA Qilian International Corp (QLI)|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Acelyrin, Inc. SLRN|TFFP: Nilai perusahaan marang bathi operasional sadurunge panyusutan
